Position in RVMD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$92,801,394
+$25,073,170 QoQ
Shares Held
954,256
+12.2% QoQ
Ownership
0.449%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.97610704045874.ToString("F0")%
Shared 0.023892959541255174.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,450,444 across 417 Biotechnology names. RVMD ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in RVMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,801,394 | 954,256 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $67,728,224 | 850,323 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $40,140,889 | 859,548 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $31,515,157 | 856,623 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $54,269,005 | 1,534,757 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $67,363,009 | 1,540,078 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $59,466,909 | 1,311,288 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $45,796,419 | 1,180,016 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $39,135,952 | 1,214,271 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $36,446,400 | 1,270,795 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $25,828,898 | 933,125 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $24,548,287 | 917,693 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,015,163 | 785,557 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,094,504 | 675,672 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,955,250 | 656,960 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,457,304 | 639,164 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,067,447 | 629,849 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $14,121,752 | 561,055 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $15,396,465 | 559,668 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,962,140 | 565,915 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $21,648,614 | 471,853 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $17,588,648 | 444,270 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $15,721,525 | 451,768 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,202,967 | 196,483 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $3,295,087 | 150,392 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||